DeepCure

About:

DeepCure leverages AI and AI-enabled technologies to advance small molecule discovery techniques.

Twitter/X: DeepCureAI

Top Investors: Creative Destruction Lab (CDL), Morningside Venture Investments, TLV Partners, The E14 Fund, IAG Capital Partners

Description:

DeepCure builds an AI engine for small-molecule drug discovery. The company is utilizing AI-driven drug discovery to expedite the advancement of groundbreaking, first-in-class precision therapeutics targeting areas with unmet medical needs.

Total Funding Amount:

$71.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2018-09-04

Contact Email:

info(AT)deepcure.ai

Founders:

Joseph Jacobson, Kfir Schreiber, Thrasyvoulos Karydis

Number of Employees:

11-50

Last Funding Date:

2024-04-11

IPO Status:

Private

Industries:

Product Research

Biotechnology

Machine Learning

Artificial Intelligence (AI)